CMS is seeking comments on a proposed coverage with evidence development for chimeric antigen receptor T-cell (CAR-T) therapy for relapsed or refractory cancer when prescribed by the treating oncologist.
This week’s Medicare updates include a proposed decision memo on coverage for CAR T-Cell therapy, an updated OIG work plan, the announcement of a new emergency services payment model, and more!
This week’s Medicare updates include a transmittal implementing the new skilled nursing facility payment model, the introduction of a new app displaying Medicare coverage information, a transmittal about updates to provider enrollment policies, and more!
Federal fraud watchdog agencies may be taking a closer look at Medicare Advantage in 2019, according to a recent report released by Bass, Barry & Sims, a Washington, D.C.-based law firm.
This week’s Medicare updates include a Special Edition MLN Matters article on the removal of total knee arthroplasty from the inpatient-only list, manual changes related to functional reporting requirements and outpatient therapy caps, the April 2019 quarterly average sales price drug pricing files, and more!
Q: How far in advance are we required to provide an Advance Beneficiary Notice of Noncoverage (ABN)? If multiple entities are involved in ordering and providing a noncovered service such as a lab test, does each entity need to issue a separate ABN?
